PROCEPT BioRobotics Corp <PRCT.O>: UBS assumes coverage with neutral vs buy rating; target price $20 vs $30
PRCT•Related News
India's Larsen and Toubro secures AI data centre order worth up to $1.57 billion
NVDA•
Cisco falls despite upbeat 2027 revenue forecast
CSCO•
Robinhood Ventures Fund II (RVII) Announces Pricing Of IPO
HOOD•
Bangladesh curbs power use as gas shortages worsen
XLE•
Norway central bank keeps rate on hold, still eyes hike
TLT•